In clinical trials in pancreatic ductal adenocarcinoma using IFNα in combination with radiation, 5-fluorouracil (5-FU) and cisplatin, patients had increased 2- and 5-year survival (53–55). The gene discussed is IFNA2; the disease is pancreatic ductal adenocarcinoma.